Loading clinical trials...
Loading clinical trials...
Phase I Trial of Copper Chelator in Conjunction With Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-resistant/-Refractory Epithelial Ovarian Cancer, Tubal Cancer and Primary Peritoneal Cancer
Conditions
Interventions
trientine dihydrochloride
pegylated liposomal doxorubicin
+1 more
Start Date
September 1, 2012
Primary Completion Date
October 1, 2015
Completion Date
December 1, 2019
Last Updated
November 10, 2020
NCT04657068
NCT05281471
NCT07001748
NCT06511037
NCT06290193
NCT06855706
Lead Sponsor
National Cheng-Kung University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions